A comprehensive view of pfizer inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published:
April 24, 2024
by CE Noticias Financieras (Latin America)
|
Pfizer Declares Second-Quarter 2024 Dividend
Published:
April 24, 2024
by Pfizer Inc.
|
US Patent Issued to Pfizer on April 23 for "Heteroaromatic compounds and their use as dopamine D1 ligands" (Massachusetts, Connecticut, Colorado Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to PFIZER on April 23 for "Modulators of STING (stimulator of interferon genes)" (California, Connecticut Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
Pfizer Canada and McMaster University partner to address health equity gaps in vaccine development and delivery; Pfizer invests C$500,000 into McMaster's Global Nexus for training scholars from underrepresented groups in vaccinology
Published:
April 23, 2024
by PR Web
|
Ask us about our Health Care Sector market view